$3.97
0.041.02%
At close: -
$3.98
0.010000.25%
After Hours: 5:56 PM EDT
Vivos Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Vivos Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $-0.40 | $-0.70 | 42.9 % |
Q2 | 2024-08-14 | $-0.60 | $-1.05 | 42.9 % |
Q4 | 2024-03-28 | $-3.05 | $-1.90 | -60.5 % |
Q2 | 2023-08-16 | $-4.50 | $-3.50 | -28.6 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $3.86M | $4.18M | -7.66 % |
Q2 | 2024-08-14 | $4.05M | $3.60M | 12.6 % |
Q4 | 2024-03-28 | $3.25M | $3.41M | -4.75 % |
Q2 | 2023-08-16 | $3.40M | $4.15M | -18.2 % |
Vivos Therapeutics (VVOS) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.40, which beat the estimate of $-0.70.
The Actual Revenue was $3.9M, which missed the estimate of $4.2M.
Browse earnings estimates, EPS, and revenue on all stocks.